19 June 2013
Keywords: glaxosmithkline, sales, growth, eps, rise, line, expectations
Article | 13 February 2006
The world's second-largest drugmaker by sales, GlaxoSmithKline, has posted a strong set of results for 2005, showing turnover up 7% at
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
13 February 2006
18 June 2013
© 2013 thepharmaletter.com